09:54 AM EST - Ventripoint Diagnostics Ltd. : Has successfully completed the Medical Device Single Audit Program re-certification for its Quality Management System under ISO 13485:2016 regulations and the FDA Quality System Regulations, which facilitates continued design, manufacturing, installation and servicing of its products in Canada and the United States. Ventripoint Diagnostics Ltd.
shares V.VPT are trading down $0.005 at $0.34.
